Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Fluvastatin
Generic Name
Fluvastatin
Active Ingredient
FluvastatinCategory
Other
Salt Form
Sodium
Variants
7
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 20 mg/1 | CAPSULE | ORAL | 0093-7442 |
| 40 mg/1 | CAPSULE | ORAL | 0093-7443 |
| 20 mg/1 | CAPSULE | ORAL | 63629-8812 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Fluvastatin, you must consult a qualified healthcare professional.
| 40 mg/1 | CAPSULE | ORAL | 63629-8737 |
| 40 mg/1 | CAPSULE | ORAL | 72162-1034 |
| 40 mg/1 | CAPSULE | ORAL | 71335-2933 |
| 40 mg/1 | CAPSULE | ORAL | 71335-2661 |
Detailed information about Fluvastatin
Fluvastatin is an HMG-CoA reductase inhibitor (statin) used to lower LDL cholesterol and triglycerides while increasing HDL cholesterol. It is indicated for the primary and secondary prevention of cardiovascular disease and the management of hyperlipidemia.
The dosage of fluvastatin is individualized based on the patient's baseline LDL cholesterol levels, the goal of therapy, and the patient's response to treatment.
Fluvastatin is approved for pediatric patients with heterozygous familial hypercholesterolemia (HeFH) between the ages of 9 and 16 years.
Since fluvastatin is primarily cleared through the liver (biliary excretion), mild to moderate renal impairment usually does not require a dose adjustment. However, for patients with severe renal impairment (creatinine clearance < 30 mL/min), healthcare providers should exercise caution and monitor the patient closely when doses exceed 40 mg per day.
Fluvastatin is contraindicated in patients with active liver disease or unexplained, persistent elevations in serum transaminases (liver enzymes). In patients with a history of liver disease or heavy alcohol use, the drug should be used with extreme caution.
Clinical studies have shown that the efficacy and safety of fluvastatin in patients aged 65 and older are similar to those in younger adults. However, because elderly patients are more likely to have decreased renal function or be taking multiple medications (polypharmacy), they may be at a higher risk for statin-associated muscle symptoms.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose (within 12 hours), skip the missed dose and return to your regular dosing schedule. Do not take two doses at once to make up for a missed one, as this increases the risk of toxicity.
In the event of an overdose, seek emergency medical attention or contact a Poison Control Center immediately. While there is no specific antidote for fluvastatin overdose, treatment is generally supportive. Symptoms of overdose may include severe nausea, vomiting, diarrhea, or muscle pain. Healthcare providers will typically monitor liver function and creatine kinase (CK) levels to assess for muscle damage.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop taking the medication without medical guidance, as this may lead to a rapid increase in cholesterol levels.
While fluvastatin is generally well-tolerated, some patients may experience mild side effects as their body adjusts to the medication. These often resolve within a few weeks of starting treatment.
Fluvastatin is a potent medication that requires careful medical supervision. Before starting therapy, patients must undergo a thorough medical history review and baseline blood tests. It is essential to understand that while fluvastatin reduces the risk of cardiovascular events, it must be used as part of a comprehensive lifestyle modification program.
No FDA black box warnings for Fluvastatin.
Fluvastatin, like other statins, can occasionally cause myopathy, defined as muscle pain, tenderness, or weakness with creatine kinase (CK) values above 10 times the upper limit of normal. The risk is dose-dependent and increases with the concurrent use of certain medications (see Interactions). Risk factors include being over age 65, having untreated hypothyroidism, or having renal impairment.
FDA Category X (Traditional): Fluvastatin is contraindicated in pregnancy. Although the FDA has recently requested the removal of the "Category X" label for statins to allow for individualized risk assessment in very high-risk patients (e.g., those with homozygous familial hypercholesterolemia), for the vast majority of patients, the risk to the fetus far outweighs any benefit. If a patient becomes pregnant while taking fluvastatin, the drug should be discontinued immediately, and the patient should be counseled on the potential risks to the fetus.
Based on animal data, fluvastatin is excreted in breast milk. Because of the potential for serious adverse reactions in nursing infants, women taking fluvastatin should not breastfeed. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Fluvastatin is approved for use in children aged 9 to 16 years with heterozygous familial hypercholesterolemia. Clinical trials lasting up to two years showed that the drug was effective in lowering LDL and was well-tolerated, with no significant effects on growth, sexual maturation, or hormone levels. Use in children under 9 years old has not been studied and is not recommended.
Fluvastatin is a competitive inhibitor of HMG-CoA reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate. Mevalonate is the precursor for cholesterol, ubiquinone (CoQ10), and dolichols. By inhibiting this pathway, fluvastatin reduces hepatic cholesterol content. This triggers a homeostatic response where the liver upregulates LDL receptors, increasing the clearance of LDL and VLDL particles from the systemic circulation. This results in a significant reduction in total cholesterol and LDL-C.
The therapeutic effect of fluvastatin is dose-dependent. A reduction in LDL cholesterol is typically observed within 1 to 2 weeks of starting therapy, with the maximum effect reached within 4 to 6 weeks. Continuous administration is required to maintain the lipid-lowering effect. If the drug is discontinued, cholesterol levels generally return to baseline within a few weeks.
| Parameter | Value |
|---|---|
| Bioavailability | ~24% |
Common questions about Fluvastatin
Fluvastatin is primarily used to lower high levels of "bad" cholesterol (LDL) and triglycerides in the blood, while slightly increasing "good" cholesterol (HDL). It is prescribed as an addition to a heart-healthy diet for patients with primary hypercholesterolemia or mixed dyslipidemia. Additionally, it is used in patients with coronary heart disease to slow the progression of atherosclerosis and reduce the risk of needing heart procedures like angioplasty. For children aged 9 to 16, it can treat a genetic high-cholesterol condition called heterozygous familial hypercholesterolemia. Your doctor determines the use based on your specific cardiovascular risk profile.
The most common side effects reported by patients taking Fluvastatin include headache, indigestion (dyspepsia), abdominal pain, and nausea. Some people may also experience muscle aches (myalgia) or difficulty sleeping (insomnia). These symptoms are usually mild and often go away as your body becomes accustomed to the medication. If these side effects are persistent or bothersome, you should discuss them with your healthcare provider. Taking the medication with food can often help reduce the stomach-related side effects.
Moderate alcohol consumption is generally acceptable, but heavy drinking should be avoided while taking Fluvastatin. Both alcohol and Fluvastatin are processed by the liver, and combining them in large amounts can significantly increase the risk of liver damage or inflammation. If you have a history of liver disease or are a heavy drinker, your doctor may choose a different medication or monitor your liver enzymes more frequently. It is best to limit alcohol intake to no more than one or two drinks per day. Always be honest with your doctor about your alcohol consumption habits.
No, Fluvastatin is generally not considered safe during pregnancy and is contraindicated for most pregnant women. Cholesterol is essential for the healthy development of a fetus, particularly for building cell membranes and producing hormones. Because Fluvastatin blocks cholesterol production, it could potentially cause birth defects. If you are planning to become pregnant or find out you are pregnant while taking this drug, stop the medication and contact your doctor immediately. Most women are advised to use effective birth control while on statin therapy.
Fluvastatin begins to lower your cholesterol levels within the first 1 to 2 weeks of treatment. However, it typically takes 4 to 6 weeks of consistent use to see the full therapeutic effect on your lipid panel. Your doctor will likely schedule a follow-up blood test about 4 to 12 weeks after you start the medication to check how well it is working and to see if the dose needs adjustment. It is important to continue taking the medication even if you feel fine, as high cholesterol usually has no symptoms.
You should not stop taking Fluvastatin suddenly without consulting your healthcare provider first. Stopping the medication will cause your cholesterol levels to return to their previous high levels, increasing your risk of heart attack or stroke over time. If you are experiencing side effects that make you want to stop, your doctor can often adjust the dose or switch you to a different statin that you may tolerate better. In some cases, such as before a major surgery or during a serious illness, your doctor may instruct you to temporarily pause the medication.
If you miss a dose of Fluvastatin, take it as soon as you remember. If it is almost time for your next dose (specifically within 12 hours of the next scheduled dose), skip the missed dose and continue with your regular schedule. Never take two doses at the same time to make up for a missed one, as this can increase your risk of side effects like muscle pain. For the immediate-release capsules, taking them in the evening is usually best, while the XL tablets can be taken at any time as long as it is consistent.
Weight gain is not a common side effect of Fluvastatin. In fact, most patients taking Fluvastatin are encouraged to follow a weight-management program involving diet and exercise to improve their cardiovascular health. While some statins have been associated with a very slight increase in blood sugar levels, which can occasionally affect weight in patients with pre-diabetes, this is not a typical reaction. If you notice rapid or unexplained weight gain while taking this medication, you should discuss it with your doctor to rule out other underlying causes.
Fluvastatin can interact with several other medications, so it is vital to provide your doctor with a full list of everything you take. It has fewer interactions with drugs processed by the CYP3A4 enzyme (like grapefruit juice) compared to other statins, but it does interact with CYP2C9 inhibitors like fluconazole. Serious interactions can occur with fibrates (like gemfibrozil), cyclosporine, and colchicine, which can increase the risk of muscle damage. Always consult your pharmacist or doctor before starting any new over-the-counter drugs or supplements.
Yes, Fluvastatin is available as a generic medication in both its immediate-release capsule and extended-release tablet forms. Generic versions are required by the FDA to have the same active ingredient, strength, dosage form, and route of administration as the brand-name drugs (Lescol and Lescol XL). Choosing the generic version can significantly reduce your out-of-pocket costs while providing the same cholesterol-lowering benefits. Check with your insurance provider or pharmacist to see which version is covered under your specific plan.
Other drugs with the same active ingredient (Fluvastatin)
> Warning: Stop taking Fluvastatin and call your doctor immediately if you experience any of these serious symptoms.
There are currently no FDA black box warnings for fluvastatin. However, the drug carries strong warnings regarding pregnancy and liver disease, which were previously handled via the highest level of precaution in the labeling.
Report any unusual symptoms to your healthcare provider. It is helpful to keep a diary of any new symptoms that begin after starting fluvastatin to discuss during your follow-up appointments.
Statins interfere with cholesterol synthesis and, theoretically, might blunt adrenal and/or gonadal steroid production. Clinical studies have shown that fluvastatin does not typically reduce basal plasma cortisol concentration or affect adrenal reserve, but caution should be used if a statin is administered with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole.
Although not seen in human fluvastatin trials, CNS vascular lesions (hemorrhages and edema) have been observed in dogs treated with other members of this drug class. Patients should be monitored for any unexplained neurological changes.
To ensure the safety and efficacy of fluvastatin, healthcare providers will typically order the following tests:
Fluvastatin is not known to interfere with the ability to drive or operate heavy machinery. However, if you experience dizziness or blurred vision as a side effect, you should avoid these activities until you know how the medication affects you.
Excessive alcohol consumption can increase the risk of liver damage when taking fluvastatin. Patients who consume substantial quantities of alcohol or have a history of liver disease should discuss their habits honestly with their healthcare provider. Most doctors recommend limiting alcohol to no more than one drink per day for women and two for men.
Fluvastatin should be temporarily withheld in any patient experiencing an acute, serious condition suggestive of myopathy or having a risk factor predisposing to the development of renal failure secondary to rhabdomyolysis (e.g., severe sepsis, hypotension, major surgery, trauma, or severe metabolic/endocrine/electrolyte disorders).
> Important: Discuss all your medical conditions, including any history of liver disease, kidney problems, or alcohol use, with your healthcare provider before starting Fluvastatin.
Fluvastatin does not typically interfere with standard laboratory tests, but it will significantly alter lipid panel results (which is the intended effect). It may also cause transient elevations in urine protein in some patients, though this is usually not indicative of kidney damage.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter drugs like ibuprofen or cold medicines.
While fluvastatin is chemically distinct from fungal-derived statins, patients who have experienced severe myopathy or rhabdomyolysis on one statin are at an increased risk of experiencing it on another. Cross-sensitivity for allergic reactions (rashes) between different statins is possible but not guaranteed.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous reactions to cholesterol medications, before prescribing Fluvastatin.
In clinical trials, no overall differences in safety or effectiveness were observed between patients over 65 and younger subjects. However, the elderly are more susceptible to myopathy due to factors like reduced muscle mass, multiple comorbidities, and the use of interacting medications. Healthcare providers may choose to start at the lower end of the dosing range for this population.
Fluvastatin is primarily metabolized by the liver. In patients with hepatic insufficiency, the plasma concentration of the drug can increase significantly. It is contraindicated in active liver disease. In patients with stable, chronic liver disease, fluvastatin must be used with extreme caution and frequent monitoring of liver enzymes.
> Important: Special populations require individualized medical assessment and more frequent monitoring to ensure the safest possible treatment outcomes.
| Protein Binding | >98% (primarily albumin) |
| Half-life | 1.2 - 3 hours (Immediate Release) |
| Tmax | 0.5 - 1.0 hours (Capsules); 3 hours (XL) |
| Metabolism | Primarily Hepatic (CYP2C9) |
| Excretion | Fecal (~95%), Renal (<5%) |
Fluvastatin belongs to the HMG-CoA reductase inhibitor class (statins). Within this class, it is categorized as a synthetic statin and a Type II statin, distinguished by its fluorinated phenyl group. Compared to other statins like atorvastatin or rosuvastatin, fluvastatin is considered a low-to-moderate potency statin, making it a preferred choice for patients who require modest LDL reduction or those who are sensitive to the side effects of more potent statins.